COMMUNIQUÉS West-GlobeNewswire

Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08/03/2024
REDWOOD CITY, Calif., March 08, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, [...]
Better Choice Company To Effectuate a Reverse Stock Split
08/03/2024
TAMPA, Fla., March 08, 2024 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (NYSE American: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, announced today that it will proceed with a 1-for- [...]
NurExone establishing State-of-the-Art Research and Development Facility in Haifa, Israel
08/03/2024
Joins exclusive group of innovative companies headquartered on Technion Campus TORONTO and HAIFA, Israel, March 08, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (Germany: J90) (the “ Company ” or “ [...]
Structure Therapeutics to Present at Leerink Partners Global Biopharma Conference
08/03/2024
SAN FRANCISCO, March 08, 2024 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and [...]
89bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
08/03/2024
SAN FRANCISCO, March 08, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative [...]
Akero Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
08/03/2024
SOUTH SAN FRANCISCO, Calif., March 08, 2024 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic disease marked [...]
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08/03/2024
BEDFORD, Mass., March 08, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on March 1, 2024, Anika granted non [...]
Evn Introduces a Game-Changer in Cannabis Edibles with New Hemp-Derived Live Resin Gummies
08/03/2024
NEW YORK, March 08, 2024 (GLOBE NEWSWIRE) -- Evn , a pioneering company in the hemp industry, has just announced the launch of its groundbreaking product – Hemp-derived Live Resin Gummies . Each pouch is bursting with [...]
InkSpace Imaging makes their advanced MRI coils available to Siemens Healthineers Magnetom Scanners
08/03/2024
PLEASANTON, Calif., March 08, 2024 (GLOBE NEWSWIRE) -- InkSpace Imaging proudly announces a major leap forward in advancing diagnostic imaging capabilities. Today, the company revealed the successful certification of [...]
Wegovy® approved in the US for cardiovascular risk reduction in people with overweight or obesity and established cardiovascular disease
08/03/2024
Bagsværd, Denmark, 8 March 2024 – Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved a label expansion for Wegovy ® based on a supplemental New Drug Application (sNDA) for the [...]
Biosplice Therapeutics Announces Department of Defense (DoD) Award to Fund Collaboration with The Roskamp Institute to Advance its Neurology Program
08/03/2024
The competitive Department of Defense “Traumatic Brain Injury and Psychological Health Research Program (TBIPHRP) Translational Research Award” will fund preclinical development of Biosplice’s DYRK inhibitors in [...]
EssilorLuxottica: 2023 Universal Registration Document filed
08/03/2024
2023 Universal Registration Document filed Charenton-le-Pont, France (March 8, 2024 – 6:30 pm) – EssilorLuxottica announces the availability of its 2023 Universal Registration Document, in accordance with applicable [...]
EssilorLuxottica: Mise à disposition du Document d’enregistrement universel 2023
08/03/2024
Mise à disposition du Document d’enregistrement universel 2023 Charenton-le-Pont, France (8 mars 2024 – 18h30) – EssilorLuxottica annonce la mise à disposition de son Document d’enregistrement universel 2023 dans les [...]
NeuroOne® to Participate in the 36th Annual Roth Conference
08/03/2024
EDEN PRAIRIE, Minn., March 08, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and [...]
MEDIA ADVISORY: New Report on Ottawa clinic exposes the “Wild West” created by Ontario’s rush to for-profit health care
08/03/2024
Attn: Assignment Editor OTTAWA, March 08, 2024 (GLOBE NEWSWIRE) -- A new report to be released Friday contains shocking revelations about the ownership and management behind private health clinics in Ottawa. Based on a [...]
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
08/03/2024
Company announcement – No. 13 / 2024 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, Denmark, March [...]
Trinity Biotech Regains Compliance with Nasdaq Minimum Closing Bid Price Rule
08/03/2024
DUBLIN, Ireland, March 08, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech Plc. (NASDAQ: TRIB) (the “Company”) today reported the receipt of a formal notification from The Nasdaq Stock Market LLC ("Nasdaq") that the Company [...]
Kymera Therapeutics Presents Preclinical Data for STAT6 and TYK2 First-In-Class, Oral Degrader Immunology Programs at the American Academy of Dermatology Annual Meeting
08/03/2024
KT-621 (STAT6) and KT-294 (TYK2) have the potential to provide biologics-like activity with oral small molecule profiles KT-621 (STAT6) expected to start Phase 1 in second half of 2024 and KT-294 (TYK2) expected to [...]
DBV Technologies announces filing of 2023 Annual Report on Form 10-K and Universal Registration Document
08/03/2024
Montrouge, France, March 8, 2024 DBV Technologies announces filing of 2023 Annual Report on Form 10-K and Universal Registration Document DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT [...]

Pages